SS

Sunita Shankar Jagtap

Active Director Designated Partner DIN 09289388
DIN 09289388 First appointment Aug 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunita Shankar Jagtap

Data last updated:

Sunita Shankar Jagtap is a Designated Partner at Parman Healthcare Llp (since 2021). The company operates in Pharma.

DIN 09289388
Primary Designation Designated Partner
Industry Pharma
First Appointment 20 Aug 2021
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner20 Aug 20212019Active

Board colleagues of Sunita Shankar Jagtap

NameDINCompanyDesignation
Ajay Keshav Gawhale05338615Parman Healthcare LlpDesignated Partner
Salil Ajay Gawhale09285960Parman Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Parman Healthcare Llp
Premium access

Shareholding and investment profile for Sunita Shankar Jagtap

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Shankar Jagtap

Sunita Shankar Jagtap currently holds 1 directorship: Parman Healthcare Llp (Designated Partner, since 20 Aug 2021).

Sunita Shankar Jagtap was first appointed on 20 Aug 2021 as Designated Partner at Parman Healthcare Llp.

The current boards of Sunita Shankar Jagtap's companies include Ajay Keshav Gawhale (Parman Healthcare Llp), Salil Ajay Gawhale (Parman Healthcare Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available